Evidence map›Paper›PMID 41281111›Full record

ArticleCureus2025

Adult-Onset Still's Disease (AOSD) Complicated by Haemophagocytic Lymphohistiocytosis (HLH) and Transient Thyrotoxicosis: A Diagnostic Challenge.

Hana Sultan, Nishchil Patel

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hana SultanDepartment of Internal Medicine, University Hospitals Plymouth NHS Trust, Plymouth, GBR.
Nishchil PatelDepartment of Endocrinology, University Hospitals Plymouth NHS Trust, Plymouth, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adult-onset Still's disease (AOSD) is a rare systemic autoinflammatory disorder that can mimic infectious, autoimmune, and endocrine conditions. Overlapping features may delay diagnosis, as in this case, which was further confounded by abnormal thyroid function tests. A 20-year-old woman presented with persistent fever, migratory arthralgia, myalgia, and a widespread urticarial rash following a sore throat. Initial work-up suggested thyrotoxicosis with weakly positive anti-TSH receptor antibodies, leading to treatment for presumed Graves' disease. Despite therapy, she experienced recurrent admissions with worsening rash, polyarthritis, cytopenia, and seizures. Serial investigations revealed markedly elevated inflammatory markers and ferritin, evolving splenomegaly, and biochemical features of systemic inflammation. Autoimmune and infectious screens were negative. She fulfilled the criteria for AOSD complicated by haemophagocytic lymphohistiocytosis (HLH). Treatment with anakinra and dexamethasone achieved marked clinical improvement, with subsequent normalization of hematological and thyroid profiles. AOSD with HLH is a life-threatening overlap syndrome requiring urgent recognition and treatment. Markedly elevated ferritin levels and multi-system involvement are pivotal diagnostic clues. Thyroid dysfunction, including transient thyroiditis, may occur in systemic inflammatory states, potentially delaying diagnosis. This case highlights the importance of systematic re-evaluation when clinical and biochemical findings diverge from a presumed single-organ pathology. Early multidisciplinary involvement and targeted therapy can be lifesaving in AOSD-HLH.

Indexed as

adult-onset still’s disease (aosd)autoimmune thyrotoxicosishaemophagocytic lymphohistiocytosis (hlh)high ferritinthyroiditis

Identifiers

PMID41281111
PMCPMC12637999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.